Kbd 001 companion diagnostic - Keystone Bio
Alternative Names: KBd-001; KBd-001 CDxLatest Information Update: 31 May 2023
At a glance
- Originator Keystone Bio
- Class Diagnostic agents
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Inflammation; Periodontal disorders
Most Recent Events
- 20 Apr 2023 Preclinical trials in Inflammation (Diagnosis) in USA (unspecified route) (Keystone Bio pipeline, April 2023)
- 20 Apr 2023 Preclinical trials in Periodontal disorders (Diagnosis) in USA (unspecified route) (Keystone Bio pipeline, April 2023)